Octreotide for acute esophageal variceal bleeding: A meta-analysis

Gastroenterology

Volumn 120, Issue 4, 2001, Pages 946-954

  Corley, Douglas A ^a   Cello, John P ^a   Adkisson, Wayne ^a   Ko, Wei Fang ^a   Kerlikowske, Karla ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OCTREOTIDE; PLACEBO; TERLIPRESSIN; VASOPRESSIN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA BASE; DRUG EFFICACY; DRUG SAFETY; ESOPHAGUS VARICES BLEEDING; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK BENEFIT ANALYSIS; SCLEROTHERAPY; SIDE EFFECT;

EID: 0035123250     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2001.22451     Document Type: Article

References (41)

1. Upper gastrointestinal hemorrhage (UGIH): Predicting rebleeding from non-endoscopic clinical parameters
2. Approach to the management of bleeding esophageal varices: Role of somatostatin
3. A meta-analysis of somatostatin versus vasopressin in the management of acute esophageal variceal hemorrhage
4. Somatostatin v placebo in bleeding oesophageal varices: Randomised trial and meta-analysis
5. Somatostatin or octreotide versus endoscopic sclerotherapy in acute variceal haemorrhage: A meta-analysis study
6. Somatostatin and octreotide in the management of acute variceal hemorrhage
7. 48-Hour hemodynamic effects of octreotide on postprandial splanchnic hyperemia in patients with liver cirrhosis and portal hypertension: Double-blind, placebo-controlled study
8. Effects of different octreotide dosages on splanchnic hemodynamics and glucagon in healthy volunteers
9. Sclerotherapy with or without somatostatin or octreotide in the treatment of acute variceal haemorrhage: Our experience
10. Sclerotherapy with or without octreotide for acute variceal bleeding
11. A randomized controlled trial comparing octreotide and vasopressin in the control of acute esophageal variceal bleeding
12. A prospective randomized controlled trial of sandostatin and vasopressin in the management of acute bleeding esophageal varices
13. A comparison of SMS 201-995 and oesophageal tamponade in the control of acute variceal haemorrhage
14. Octreotide versus terlipressin in acute variceal hemorrhage in liver cirrhosis. Emergency control and prevention of early rebleeding
15. Octreotide infusion or emergency sclerotherapy for variceal haemorrhage
16. Prospective randomised study of effect of octreotide on rebleeding from oesophageal varices after endoscopic ligation
17. Terlipressin plus transdermal nitroglycerin vs. octreotide in the control of acute bleeding from esophageal varices: A multicenter randomized trial
18. A multicentre randomised trial comparing octreotide and injection sclerotherapy in the management and outcome of acute variceal haemorrhage
19. Review article: The role of pharmaco-therapy for acute variceal haemorrhage in the era of endoscopic haemostasis
20. Hold that needle: Octreotide for acute variceal hemorrhage
21. Sclerotherapy plus octreotide versus sclerotherapy alone in the prevention of early rebleeding from esophageal varices: A randomized, double-blind, placebo-controlled, multicenter trial. New Italian Endoscopic Club
22. Double blind RCT of 5 day octreotide versus placebo, associated with sclerotherapy for trial/failures
23. Upper digestive hemorrhage. Comparison of terlipressin and octreotide
24. Somatostatin or octreotide compared with H2 antagonists and placebo in the management of acute nonvariceal upper gastrointestinal hemorrhage: A meta-analysis
25. Resolving conflicting clinical trials: Guidelines for meta-analysis
26. Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
27. Bias in treatment assignment in controlled clinical trials
28. Assessing the quality of randomization from reports of controlled trials published in obstetrics and gynecology journals
29. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials
30. Meta-analysis: When and how
31. Meta-analysis in clinical trials
32. Models for estimating the number of unpublished studies
33. Octreotide vs. sclerotherapy in the control of acute variceal bleeding in schistosomal portal hypertension: A randomized trial
34. Comparison of octreotide, vasopressin and SB tube for acute bleeding of esophageal varices. A prospective randomized trial
35. Esophageal varices bleeding: Comparison between treatment with sclerotherapy alone vs sclerotherapy plus octreotide
36. Comparison of endoscopic variceal sclerotherapy alone and in combination with octreotide in controlling acute variceal hemorrhage and early rebleeding in patients with low-risk cirrhosis
37. Sandostatin therapy of acute oesophageal variceal bleeding
38. Emergency banding ligation versus sclerotherapy for the control of active bleeding from esophageal varices
39. Sclerotherapy versus ligation in hemorrhage caused by rupture of esophageal varices. Direct meta-analysis of randomized trials